Pentheroudakis, G., Kotoula, V., De Roock, W., Kouvatseas, G., Papakostas, P., Makatsoris, T., . . . Fountzilas, G. (2013). Biomarkers of benefit from cetuximab-based therapy in metastatic colorectal cancer: Interaction of EGFR ligand expression with RAS/RAF, PIK3CA genotypes. BioMed Central.
Citação norma ChicagoPentheroudakis, George, et al. Biomarkers of Benefit From Cetuximab-based Therapy in Metastatic Colorectal Cancer: Interaction of EGFR Ligand Expression With RAS/RAF, PIK3CA Genotypes. BioMed Central, 2013.
MLA引文Pentheroudakis, George, et al. Biomarkers of Benefit From Cetuximab-based Therapy in Metastatic Colorectal Cancer: Interaction of EGFR Ligand Expression With RAS/RAF, PIK3CA Genotypes. BioMed Central, 2013.
警告：這些引文格式不一定是100％准確.